Skip to content
Spiritual Quotes – Lifestyle
Author:
AMGEN
AMGEN ANNOUNCES POSITIVE PHASE 3 RESULTS FOR DAZODALIBEP IN SJÖGREN’S DISEASE
November 11, 2026
NEW DATA AT AHA 2026 DEMONSTRATES THE VALUE OF TREATMENT WITH REPATHA® EARLIER IN THE CARDIOVASCULAR RISK CONTINUUM
November 9, 2026
REPATHA® LOWERS RISK OF HEART ATTACKS BY 20% COMPARED WITH EZETIMIBE IN A LARGE REAL-WORLD STUDY
November 5, 2026
AMGEN REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS
November 3, 2026
AMGEN ANNOUNCES WEBCAST OF 2026 THIRD QUARTER FINANCIAL RESULTS
October 28, 2026
AMGEN ANNOUNCES 2026 FOURTH QUARTER DIVIDEND
October 27, 2026
AMGEN TO PRESENT NEW DATA ACROSS RARE AND OTHER SERIOUS AUTOIMMUNE DISEASES AT ACR CONVERGENCE 2026
October 27, 2026
AMGEN APPOINTS DAVID W. GIBBS TO BOARD OF DIRECTORS
October 26, 2026
IMDELLTRA® IN COMBINATION WITH IMFINZI® REDUCED RISK OF DEATH BY AN UNPRECEDENTED 58% IN FIRST-LINE EXTENSIVE STAGE SMALL CELL LUNG CANCER
October 24, 2026
AMGEN TO PRESENT AT THE EUROPEAN SOCIETY OF MEDICAL ONCOLOGY CONGRESS 2026
October 20, 2026
1
2
3
Next Page
→